A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Quinethazone
Salicylamide
The risk or severity of renal failure and hypertension can be increased when Salicylamide is combined with Aliskiren.
Quinethazone
Parecoxib
The risk or severity of renal failure and hypertension can be increased when Parecoxib is combined with Aliskiren.
Quinethazone
Azapropazone
The risk or severity of renal failure and hypertension can be increased when Azapropazone is combined with Aliskiren.
Quinethazone
Zaltoprofen
The risk or severity of renal failure and hypertension can be increased when Zaltoprofen is combined with Aliskiren.
Quinethazone
Aceclofenac
The risk or severity of renal failure and hypertension can be increased when Aceclofenac is combined with Aliskiren.
Quinethazone
Lornoxicam
The risk or severity of renal failure and hypertension can be increased when Lornoxicam is combined with Aliskiren.
Quinethazone
Cimicoxib
The risk or severity of renal failure and hypertension can be increased when Cimicoxib is combined with Aliskiren.
Quinethazone
Zomepirac
The risk or severity of renal failure and hypertension can be increased when Zomepirac is combined with Aliskiren.
Quinethazone
Metamizole
The risk or severity of renal failure and hypertension can be increased when Metamizole is combined with Aliskiren.
Quinethazone
Benoxaprofen
The risk or severity of renal failure and hypertension can be increased when Benoxaprofen is combined with Aliskiren.
Quinethazone
Nimesulide
The risk or severity of renal failure and hypertension can be increased when Nimesulide is combined with Aliskiren.
Quinethazone
Licofelone
The risk or severity of renal failure and hypertension can be increased when Licofelone is combined with Aliskiren.
Quinethazone
Taxifolin
The risk or severity of renal failure and hypertension can be increased when Taxifolin is combined with Aliskiren.
Quinethazone
Etoricoxib
The risk or severity of renal failure and hypertension can be increased when Etoricoxib is combined with Aliskiren.
Quinethazone
Tiaprofenic acid
The risk or severity of renal failure and hypertension can be increased when Tiaprofenic acid is combined with Aliskiren.
Quinethazone
Antrafenine
The risk or severity of renal failure and hypertension can be increased when Antrafenine is combined with Aliskiren.
Quinethazone
Choline magnesium trisalicylate
The risk or severity of renal failure and hypertension can be increased when Choline magnesium trisalicylate is combined with Aliskiren.
Quinethazone
Salsalate
The risk or severity of renal failure and hypertension can be increased when Salsalate is combined with Aliskiren.
Quinethazone
Magnesium salicylate
The risk or severity of renal failure and hypertension can be increased when Magnesium salicylate is combined with Aliskiren.
Quinethazone
Cilazaprilat
The risk or severity of hypotension, hyperkalemia, and nephrotoxicity can be increased when Aliskiren is combined with Cilazaprilat.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3